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1. Introduction
Endoscopy is a fast moving field, and new techniques are constantly emerging. In recent
decades, gastrointestinal endoscopy has evolved and branched out from a visual diagnostic
modality, using fibreoptic bundles, to enhanced video and computer assisted imaging, with
impressive interventional capabilities. Some new endoscopic techniques will be too complex
or expensive to make the leap into general gastroenterology practice, others already show
major progress in the management of digestive diseases. In this chapter we will discuss
some of the emerging techniques and technologies used to increase the diagnostic yield in
the colon and small intestine including third eye retroscopes, colon capsule endoscopy, bal‐
loon and spiral enteroscopy and confocal laser endomicroscopy. We will also discuss over
the scope clip (OTSC) devices, a relatively simple and inexpensive tool potentially capable
of closing noninvasively intestinal perforations and allowing the removal of infiltrating tu‐
mors. Experimental modalities such as natural orifice translumenal endoscopic surgery
(NOTES) will also be discussed, with emphasis on their future clinical use. We will also fo‐
cus on endoscopic ultrasonography (EUS), which has moved from an experimental techni‐
que to a valuable established diagnostic modality which not only competes with modern
imaging modalities such as MRI, but is also particularly useful in the interventional setting
especially in pancreatic and hepatobiliary pathology. We will also discuss the importance of
training endoscopists in the use of these new techniques and we will offer some speculation
on which of them may become really useful in routine patient care or remain restricted to
large teaching hospitals.
© 2013 Van Den Bogaerde and Sorrentino; licensee InTech. This is an open access article distributed under
the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which
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2. Improving adenoma detection rate during colonoscopy
The most important task of endoscopists is the early detection and timely removal of co‐
lonic  polyps.  After  completing  a  colonoscopy,  the  endoscopist  should be  confident  that
all  polyps  have  been  removed,  including  proximal  flat  lesions.  Polyps  are  however
missed  in  up  to  35%  of  colonoscopies,  and  proximal  adenomas  are  more  frequently
missed [1].  Proximal sessile serrated adenomas are particularly difficult to diagnose, but
are  present  in  up to  13% of  screening colonoscopies,  and result  in  colorectal  malignan‐
cies  [2].  Variation in detection rates  is  related to endoscopic skill  and training.  Real  life
data  show that  colonoscopy reduced mortality  from colorectal  cancer  by  65% [3].  Can‐
cers  developing  3  years  after  a  colonoscopy  almost  certainly  represent  missed  lesions,
and as many as 14.4% of right sided neoplasms are not detected during conventional co‐
lonoscopy [4].  The data show that endoscopists should focus on improving detection of
right sided colonic lesions,  where missed lesions and reduction in mortality is  not opti‐
mal [5,6].
2.1. Retroflexion in cecum
The folds of  the colon hide neoplastic  lesions,  and the majority (93.3%) of  undiagnosed
polyps  hide  behind  folds  [7].  Endoscopists  know  that  rectal  lesions  close  to  the  anal
verge  are  difficult  to  see,  and  experienced  operators  do  a  thorough  rectal  examination
and retroflex in the rectum to avoid missing these lesions. According to these principles
cecalretroflexion  with  withdrawal  and  evaluation  of  the  folds  of  the  ascending  colon
should  also  be  useful.  A  recent  report  has  documented  that  cecalretroflexion  was  safe,
achievable in 94.4%, and increased adenoma detection rate by 9.8% [8]. The advantage of
this  technique  is  that  conventional  equipment  is  used,  all  competent  endoscopists  can
perform this, and no perforations were documented in this study. The study is however
uncontrolled and the authors  report  that  similar  results  may be achievable  by a  careful
antegrade  second look  of  the  ascending  colon.  The  obvious  difficulty  of  examining  the
proximal colon has resulted in the development of third eye retroscopes.
2.2. Third eye devices
Third eye retroscopes are thin fibreoptic probes that fit into the working channel of a colono‐
scope and can examine folds in the ascending colon, which are not easily visible with for‐
ward viewing instruments. In controlled studies adenoma detection rates were improved,
with better detection of larger rather than smaller lesions [9-11]. Adenomas larger than 6
mm in size were detected at a 25% higher rate, and 10mm or larger lesions at 33.3% [9]. The
reason for this preferential visualization of larger and therefore more important lesions with
the retroscope was documented by other authors [10], and no clear explanation for this
somewhat surprising finding has been advanced.
In expert hands, use of retroscopes increases withdrawal time from 7.58 to 9.52 minutes [11],
but increased adenoma detection of approximately 20% seems worthwhile. A potential
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problem is that once a polyp has been detected the retroscope needs to be withdrawn, to
make way for the polyp snare, thus losing sight of the polyp. Cost issues are crucial, and
adding an expensive piece of equipment to every colonoscopy will increase costs. Indeed,
cost issues may be the most important limiting factor in the universal acceptance of this
promising new technology.
2.3. Mucosal enhancement techniques
Changing the appearance of the mucosa is now accepted as a method of increasing ade‐
noma detection. Two methods exist: dye staining and equipment settings such as narrow
band imaging.  Blue  dyes  such as  indigo carmine  and methylene  blue  are  useful  in  the
colon,  where  mucosal  definition  and  vascular  pattern  changes  are  emphasized.  Lugol’s
iodine is useful in the esophagus, but can cause patient discomfort and allergic reactions.
Dye stains increase precision of diagnosis in Barrett’s esophagus [12] and ulcerative coli‐
tis  [13].  Chromoendoscopy using indigo carmine increased adenoma detection rate  in  a
large and well  designed study,  from 36.3% to  46.2%,  with a  marginal  increase  in  with‐
drawal times [14].  It  is  surprising that dye spray is not used more to increase adenoma
detection.  Personal  experience  and  reports  from  working  endoscopists  suggest  that  the
effort involved with dye spraying reduces enthusiasm for this technique as time goes by.
Dye stains have the advantage of  being cheap,  but  also dirty,  time inefficient,  and pro‐
duce variable results [15].
Narrow band imaging (NBI) uses filters to emphasize blue coloured light, thus accentuating
vascular structures. The touch button activation of this makes it user friendly, and NBI can
accurately discriminate between hyperplastic and adenomatous polyps, according to pit
patterns with a high sensitivity and specificity [16]. Dysplasia in ulcerative colitis [17] and
early gastric cancer [18] are amenable to more precise analysis using NBI. In Barrett’s muco‐
sa, NBI has been shown to diagnose high grade dysplasia with a very high sensitivity (96%)
and specificity (94%) [19].
The problem with NBI, is that the field depth is much reduced when compared to white
light.  Inevitably  white  light  is  used to  see  an  abnormality,  and then interrogation  with
NBI assists in confirming the pathology. It certainly is a “nice to have” technique for en‐
doscopists who use it regularly, and training endoscopists to analzyse NBI enhanced mu‐
cosal  pathology  is  not  daunting  [20].  Somewhat  disappointingly  there  is  little  evidence
that  NBI increases  adenoma detection rate,  which is  really  the point  of  new equipment
[21-24].
The diagnosis of difficult-to-see flat or depressed lesions will remain a challenge, In some
studies flat lesions are documented in 9.4% of patients, and 33% of depressed lesions are
malignant [25]. Endoscopist skill, training, and continued vigilance, in conjunction with on‐
going technical advances will increase adenoma detection rate, and hopefully reduce right
sided interval cancers.




One technical advance which has improved colonoscopy, both for patients and procedural‐
ists is CO2 insufflation. Although described more than 30 years ago recent data have un‐
equivocally shown superiority to room air insufflation [26-28]. In particular, patient
recovery and distention after the procedure are markedly reduced. In our opinion, even the
smallest unit should strive to change to CO2 insufflation.
3. Colon capsule endoscopy
Although impressive advances have been made in colonic screening programs, the uptake
of colonoscopy, which is the definitive screening tool is still disappointing [29,30]. In a large
community based study the uptake of fecal occult blood testing was low (43%, 20.79% men),
with obvious limitations of outcome [31].
The perception of what a colonoscopy is, and the perceived danger and invasiveness of the
procedure contributes to poor patient uptake [32]. Other less invasive tests such as CT colo‐
nography have been suggested, but radiation and inability to detect flat polyps limit the
usefulness of this study [33].
The establishment of small bowel capsule endoscopy has resulted in the development of
colon capsule endoscopy (CCE), as an alternative to colonoscopy for diagnosis of colonic
pathology.
CCE is technically more challenging than small bowel capsule evaluation, since the capsule
has to travel through the small bowel, and then into the colon, which requires an increase in
battery life. Lesions hidden in folds are difficult to visualize, as they are for conventional co‐
lonoscopy, and the bowel has to be even cleaner than for a normal colonoscopy, since mu‐
cosal washing is not possible [34].
Technical modifications of the original colon capsule, such as larger batteries, image captur‐
ing at both ends of the capsule, and increased image capture rate to accommodate faster co‐
lonic transit have improved diagnostic accuracy [35]. Sensitivity for polyp detection with
second generation capsules is 89% [35], using colonoscopy as the gold standard.
Bowel preparation has to be rigorous [36], and some issues with capsule battery life remain
challenging. Recent evidence-based guidelines for CCE have been produced by the Europe‐
an Society for Gastrointestinal Endoscopy [37].
CCE will probably be used in the same way as CT colonography, as an useful adjunct to
colonoscopy.  In  patients  who are  at  high  risk  for  colonoscopy,  or  where  completion  of
colonoscopy is not possible, evaluation by CCE may be useful. A small percentage of pa‐
tients may be put off by colonoscopy and for them, the non invasiveness of CCE would
be attractive.  Cost comparisons would be essential  in determining exactly where the fu‐
ture of CCE lies. Adenoma detection rates in colonoscopy screening populations approxi‐
mate  50%  or  more  [14,31],  which  suggests  that  successful  screening  procedures  would
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necessitate  colonoscopy  in  a  majority  of  patients  anyway,  to  remove  visualized  adeno‐
mas. Flat lesions remain a problem, regardless of the screening modality employed.
4. Small bowel evaluation and spiral enteroscopy
Small bowel evaluation has become precise and relatively easy with small bowel capsule
evaluation. MR enterography has added excellent diagnostic capability, particularly in pa‐
tients with Crohn’sdisease [38,39].
The different radiological and capsule techniques are complementary, and evaluation of the
bowel wall and extraintestinal structures is a particular strength of MR enterography [40].
The challenge of  the small  bowel is  intervention once pathology has been found. A pa‐
tient  with  iron  deficiency  anemia  may  have  small  bowel  vascular  ectasia  which  are
amenable to Argon plasma coagulation, or a polyp which can be removed endoscopical‐
ly. In the last decade double balloon enteroscopy (DBE) has become an established tech‐
nique  with  reported  complete  small  bowel  evaluation  possible  in  40  to  80  %  [41].
Subsequently  the  single  balloon enteroscopy (SBE)  technique  was  introduced with  low‐
er  rates  of  complete  enteroscopy  (up  to  25%  of  cases)  and  a  diagnostic  yield  of  40  -
60%  [42,43].  Both  DBE  and  SBE  need  up  to  90  minutes  to  be  completed  and  are
demanding  procedures.  Complications  include  perforation  (2.3% in  SBE)  and pancreati‐
tis (0.3% in DBE) [42,43]. Interventions are sometimes difficult due to the unstable endo‐
scope position.
Spiral  enterography  is  a  new  technique  whereby  an  overtube  with  a  distal  thread  is
placed  over  a  conventional  colonoscope  and twisted  into  the  small  bowel  [44].  The  in‐
sertion time for  spiral  enterography appears  to  be shorter  than double balloon enterog‐
raphy,  but  depth  of  insertion  is  considerably  less  [45].  Stent  insertion  and  therapeutic
maneuvers  may  be  easier  with  the  spiral  technique  due  to  overtubestabilization  [46].
DBE uses  a  Fujinon  platform,  while  the  SBE uses  an  Olympus  platform.  Spiral  entero‐
scopy  has  the  advantage  of  using  different  endoscopic  platforms,  but  its  role  has  not
been sufficiently defined to make recommendations yet.
Small  bowel  pathology  is  an  important  part  of  the  work  up  in  a  substantial  propor‐
tion  of  patients  with  an  undefined  iron  deficiency  anemia.  The  chosen  diagnostic  mo‐
dality  depends  on  availability  and  expertise,  but  small  bowel  capsule  is  probably  the
choice  examination  for  the  time  being.  Once  pathology  has  been  identified,  the  depth
of  the  lesion  in  the  small  bowel  determines  which  of  the  three  interventional  modali‐
ties  is  optimal.  DBE  is  the  established  technology,  but  in  more  proximal  small  bowel
lesions,  particularly  if  stenting  is  required,  spiral  enterography  may  be  the  procedure
of  choice.  The  role  of  this  technology  outside  teaching  hospitals  awaits  good compara‐
tive  studies.
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5. ERCP and endoscopic ultrasound
Ironically the greatest advance in ERCP in the last 10 years is the development of MRCP,
which has almost completely dispensed with the need for diagnostic ERCP. Techniques
have not really changed in 10 years, although some useful stent modifications have occur‐
red. Novel stenting devices include stents impregnated with radioactive seeds, which not
only can palliatively drain obstructed common bile ducts, but also irradiate the contiguous
pancreatic malignancy [47].
The interplay between endoscopic ultrasound (EUS) and ERCP in challenging patients is
an  interesting  new  development.  ERCP  drainage  of  malignant  biliary  strictures  often
fails, and EUS drainage bypassing the papilla is feasible, and in expert hands has a high
success rate [48,49].
Patients with altered anatomy after surgery present a special challenge, and ERCP may be
impossible. In expert hands EUS can assist in placing stents, but the authors of an authora‐
tive review point out that the technical difficulties and the specialized nature of these inter‐
ventions are best left to experts in referral centres [50]. Certainly these technologies are not
going to enter community based departments soon.
Exciting applications of EUS based interventions include the now standard celiac plexus
blocks and drainage of pseudocysts, as well as inplantation of radioactive seeds and even
viral vectors in tumours, ablation of cysts, variceal cyanoacrylate injection, and vascular coil
placement [47,51-53]. Obviously these techniques are at the moment very far from main‐
stream gastroenterology.
6. Confocal laser endomicroscopy
Confocal laser endomicroscopy (CLE) is a technology which allows real time histology of
the mucosa during upper and lower endoscopy. Laser illumination of the mucosa combined
with fluorescent dye illumination enables immediate and precise “microscopic” evaluation
of mucosal lesions [54]. Fluorescent dye injection is essential for this technique, and tissue
uptake occurs within seconds of injection. There is a very extensive literature of fluorescent
dye injection in ophtalmology, confirming its excellent safety profile. The limitation of fluo‐
rescein is that it highlights cells, connective tissue and vessels but not nuclear material. Topi‐
cal application of acroflavine stains cell nuclei, and can be used separately or in addition to
fluorescein.
Depth of view of the endoscopic CLE system is up to 250 µm, while the probe system which
is inserted down the working channel of any endoscope has a more limited depth of view
[55]. The area which can be examined is limited - no more than 700 µm2 in the endoscopy
based system and even less in the smaller probe based system so precise targeting is impor‐
tant. New generation probes can be placed through needles allowing novel approaches to
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endoultrasonographic tissue sampling, hepatobiliary assessment, and even laparoscopically
assisted real time hepatic tissue histology [56].
CLE has been used extensively in evaluating Barrett’s mucosa. It has also been used in pa‐
tients with colonic neoplasia, gastric metaplasia, and celiac disease.
When used in combination with conventional endoscopy, CLE allows excellent prediction of
high grade dysplasia and malignancy in Barrett’s mucosa [57]. In addition to targeting biop‐
sies, assessment of submucosal tissue, which may be particularly important in patients who
have undergone ablation of Barrett’s dysplasia can be performed. CLE predicted malignan‐
cy in Barrett’s lesions with a specificity of 96%, and sensitivity of 88% [58]. CLE combined
with four quadrant biopsies was twice as effective in detecting neoplasia, and the majority
of patients in the CLE arm did not need biopsies at all [59].
Gastric metaplasia or malignancy are amenable to CLE evaluation, with high accuracy and
reproducibility, and significantly better accuracy than conventional endoscopy [60-62].
During colonoscopy CLE polyp evaluation, when compared with standard histology produ‐
ces sensitivity for adenoma of 97.3%, while high and low grade dysplasia was analyzed ac‐
curately in 96.7% [63]. CLE evaluation in patients with UC resulted in far higher detection of
intra-epithelial neoplasia (4.75 fold), as well as reducing the number of biopsies by half [64].
The future focus of CLE is the use of specific labeled markers in a method similar to immu‐
nohistochemistry, to light up pre malignant or malignant mucosa [65,66] The application of
this methodology beyond the research setting is however still unclear.
The concept of optical biopsies [67] has been well established for colonic and gastric neo‐
plastic lesions, particularly by Japanese endoscopists assessing flat colonic lesions, but mi‐
croscopic in vivo biopsies using CLE technology advances this concept to a new level. What
has not been addressed is the medico legal issue related to this technique. How confident
can an endoscopist be when making a diagnosis by CLE of high grade dysplasia in a patient
with Barrett’s esophagus, and use only this information to guide subsequent therapy? In
these cases the gold standard will remain conventional histopathology, with its established
and extensive guidelines.
Finally, this technology does not improve detection rate of suspicious lesions, but relies on
conventional endoscopic evaluation to target the optical biopsy. As discussed at the begin‐
ning of this chapter, the greatest problem with endoscopy is the missed lesion. Although the
reduced number of biopsies is mentioned as an advantage this is a tenuous advantage at
most. The time taken to analyze tissue by CLE, would be easily spent taking more biopsies if
clinically indicated. In a recent study the advantage of optical biopsy in patients on anticoa‐
gulation is brought forward as a reason to pursue in vivohistology [68] but current guide‐
lines do not exclude patients on anticoagulation from undergoing biopsy [69].
Although CLE appears glamorous and exciting as a technology, it has been around for al‐
most a decade, and has not really expanded its reach beyond the research setting. The time
constraints, expense and technical difficulties probably will keep this as a “nice to have”
technology in selected tertiary hospitals where enthusiasts will use it.
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7. Over the scope clip devices
Colonic perforation remains an important complication of colonoscopy, with a large recent
series reporting an alarming 0.33% rate [70].
Both diagnostic and therapeutic interventions can cause perforation, and even argon plasma
coagulation (APC) can result in perforations. Even in the best hands, perforation occurs
when complex polyps are removed, and indeed increased polyp detection and removal of
increasingly large polyps will result in more rather than less colonic endoscopic complica‐
tions [71].
Over the scope clip devices (OTSC) are pre armed on a transparent silicone cap, and are re‐
leased by winding up a pre loaded thread similar to band ligators. A large pair of forceps is
passed through the working channel to approximate the defect and pull the tissue into the
cap, followed by release of the bear trap-like device. Even deep lesions penetrating into the
serosa can be closed. OTSC devices have been successfully used in animal models to close
full thickness perforations [72]. Perforation closure strength has been shown to approximate
conventional surgical techniques [73].
In  a  small  clinical  case  report  study  perforation  closure  was  achieved  in  6  of  7  cases,
and avoidance of any surgery achieved in 4 of 7 [74]. Perforations of up to 20 mm were
managed using these clips in a clinical  setting [75],  and surgery was performed in only
one of 10 patients.
These clips have been shown to close colonic fistulae, without surgical intervention [76]. In
another report, 11 of 12 patients were treated successfully for chronic fistulae and colonic
perforations with no reported complications [77]. Placing clips is technically challenging,
but a mean procedure time of 54 minutes for fistula closure is not dauntingly long when
compared to other difficult endoscopic techniques [78].
Even refractory chronic duodenal fistula and esophageal anastomotic perforation after gas‐
trectomy have been managed by OTSC devices [78,79].
The bear trap structure of these clips does however demands caution when placing, and
very careful consideration of clip removal if placement is incorrect.
Large defects greater than 2.5 cm are not amenable to treatment with these clips, but appli‐
cation of more than one clip may be helpful. Severe fibrosis over a large area is also not ame‐
nable to clip application in patients with long standing ulcers or fistulae. Reports of
complications are scarce. One paper reports no complications [77] but post clip pain may be
due to grasping of visceral fat or peritoneum [75]. Strictures can also develop, particularly
when large portions of mucosa are grasped and clipped.
In addition, when drawing back the mucosa with forceps, the clip must not grasp the for‐
ceps during deployment, since loosening of the clip is impossible. This then results in the
clip and forceps being stuck in the channel of the endoscope, and stuck to the mucosa. Sur‐
gical removal is the only option: a true endoscopic nightmare.
Endoscopy276
OTSC devices can control bleeding in animal models [80]. A recent study of upper gastroin‐
testinal bleeding documented a 13% re-bleed rate after initial endoscopy, and a mortality of
10% [81]. Although the study does not precisely detail the endoscopic appearance of peptic
ulcers in re-bleeding patients, a substantial percentage of these patients probably had chron‐
ic fibrotic ulceration, with endoscopically difficult to control visible vessels in the ulcer base.
It is well recognized that these patients often re-bleed and need surgical intervention. Plac‐
ing conventionally available clipping devices on these vessels is challenging, dangerous and
often unsuccessful. In theory, the OTSC device offers a far better approach to these patients,
and this indication may actually become the most important of these devices.
7.1. OTSC and endoscopic submucosal dissection
Endoscopic submucosal dissection (ESD) allows en block removal of gastric and colonic neo‐
plasia. Perforation rates of 4.1% in gastric [82] and as high as 20.4% in colon lesions have
been reported [83]. OTSC devices may assist in closing some of the larger perforations in
these patients. Full thickness endoscopic resection of tumours or polyps is possible with a
combination of OTSC and snare devices [84]. In those patients where endoultrasonography
has shown invasion of the muscular wall, and endoscopic mucosal resection (EMR) or endo‐
scopic submucosal dissection (ESD) is not feasible, the OTSC device may offer a non surgical
approach for removal of these neoplastic and invasive lesions in selected patients. In partic‐
ular, this technique could be potentially useful in treating gastrointestinal stroma tumors,
granulosa cell tumours, carcinoids, or any other slowly growing neoplasms which invade
the muscular wall and are therefore not amenable to other endoscopic techniques.
7.2. NOTES
One of the problems of natural orifice translumenal endoscopic surgery (NOTES) proce‐
dures is the gastrostomy, which may be amenable to OTSC closure [85]. However, NOTES
remains a modality that has yet to find its place outside the experimental sphere. The techni‐
cal challenges of these procedures, with the relatively minimal gain of avoiding minor en‐
trance wounds in laparoscopic surgery, would suggest that these techniques may not be
going to become routine.
8. Endoscopic control of bleeding
Techniques for controlling bleeding have not substantially changed in the last decade, but a
new method of nanopowder spray seems to be both effective and easy to apply [86,87]. This
powder could be of potential benefit in difficult to control arterial bleeds, where visibility is
an issue, or as a bridge to surgery. The major advantage of this would possibly be that less
experienced endoscopists could obtain control of bleeding, without performing technically
difficult procedures. In our opinion, most senior endoscopy consultants would appreciate
this modality if it would mean that more junior consultants could safely handle emergency
bleeds.




J. Van Den Bogaerde1,2* and D. Sorrentino1,2,3
*Address all correspondence to: Johan_van_den_Bogaerde@health.qld.gov.au
1 Department of Gastroenterology, Nambour General Hospital, University of Queensland,
Australia
2 Sunshine Coast Clinical School, Australia
3 University of Udine Medical School, Udine, Italy
References
[1] Laiyemo AO, Doubeni C, Sanderson AK, Pinsky PF, Badurdeen DS, Doria-Rose VP,
et al. Likelihood of missed and recurrent adenomas in the proximal versus the distal
colon. GastrointestEndosc 2011, Aug;74(2):253-61.
[2] Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detec‐
tion of proximal colon serrated polyps during screening colonoscopy. ClinGastroen‐
terolHepatol 2011, Jan;9(1):42-6.
[3] Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorec‐
tal cancer incidence and mortality. ClinGastroenterolHepatol 2009, Jul;7(7):770-5;
quiz 711.
[4] Singh H, Nugent Z, Demers AA, Bernstein CN. Rate and predictors of early/missed
colorectal cancers after colonoscopy in manitoba: A population-based study. Am J
Gastroenterol 2010, Dec;105(12):2588-96.
[5] Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The re‐
duction in colorectal cancer mortality after colonoscopy varies by site of the cancer.
Gastroenterology 2010, Oct;139(4):1128-37.
[6] Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection
from right- and left-sided colorectal neoplasms after colonoscopy: Population-based
study. J Natl Cancer Inst 2010, Jan 1;102(2):89-95.
[7] Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adeno‐
mas missed by optical colonoscopy. Ann Intern Med 2004, Sep 9;141(5):352-9.
[8] Hewett DG, Rex DK. Miss rate of right-sided colon examination during colonoscopy
defined by retroflexion: An observational study. GastrointestEndosc 2011, Aug;74(2):
246-52.
Endoscopy278
[9] Waye JD, Heigh RI, Fleischer DE, Leighton JA, Gurudu S, Aldrich LB, et al. A retro‐
grade-viewing device improves detection of adenomas in the colon: A prospective
efficacy evaluation (with videos). GastrointestEndosc 2010, Mar;71(3):551-6.
[10] DeMarco DC, Odstrcil E, Lara LF, Bass D, Herdman C, Kinney T, et al. Impact of ex‐
perience with a retrograde-viewing device on adenoma detection rates and with‐
drawal times during colonoscopy: The third eye retroscope study group.
GastrointestEndosc 2010, Mar;71(3):542-50.
[11] Leufkens AM, DeMarco DC, Rastogi A, Akerman PA, Azzouzi K, Rothstein RI, et al.
Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy:
The TERRACE study. GastrointestEndosc 2011, Mar;73(3):480-9.
[12] Kouklakis GS, Kountouras J, Dokas SM, Molyvas EJ, Vourvoulakis GP, Minopoulos
GI. Methylene blue chromoendoscopy for the detection of barrett's esophagus in a
greek cohort. Endoscopy 2003, May;35(5):383-7.
[13] Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S, et al. Methylene
blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon
cancer in ulcerative colitis. Gastroenterology 2003, Apr;124(4):880-8.
[14] Pohl J, Schneider A, Vogell H, Mayer G, Kaiser G, Ell C. Pancolonicchromoendosco‐
py with indigo carmine versus standard colonoscopy for detection of neoplastic le‐
sions: A randomised two-centre trial. Gut 2011, Apr;60(4):485-90.
[15] Kwan V. Advances in gastrointestinal endoscopy. Intern Med J 2012, Feb;42(2):
116-26.
[16] East JE, Suzuki N, Bassett P, Stavrinidis M, Thomas HJ, Guenther T, et al. Narrow
band imaging with magnification for the characterization of small and diminutive
colonic polyps: Pit pattern and vascular pattern intensity. Endoscopy 2008, Oct;
40(10):811-7.
[17] Esaki M, Kubokura N, Kudo T, Matsumoto T. Endoscopic findings under narrow
band imaging colonoscopy in ulcerative colitis. Dig Endosc 2011, May;23Suppl
1:140-2.
[18] Zhang J, Guo S-B, Duan Z-J. Application of magnifying narrow-band imaging endos‐
copy for diagnosis of early gastric cancer and precancerous lesion. BMC Gastroenter‐
ol 2011;11:135.
[19] Mannath J, Subramanian V, Hawkey CJ, Ragunath K. Narrow band imaging for
characterization of high grade dysplasia and specialized intestinal metaplasia in bar‐
rett's esophagus: A meta-analysis. Endoscopy 2010, May;42(5):351-9.
[20] Higashi R, Uraoka T, Kato J, Kuwaki K, Ishikawa S, Saito Y, et al. Diagnostic accura‐
cy of narrow-band imaging and pit pattern analysis significantly improved for less-
experienced endoscopists after an expanded training program. GastrointestEndosc
2010, Jul;72(1):127-35.
Innovative Uses and Emerging Technologies in Endoscopy
http://dx.doi.org/10.5772/52552
279
[21] Sabbagh LC, Reveiz L, Aponte D, de Aguiar S. Narrow-band imaging does not im‐
prove detection of colorectal polyps when compared to conventional colonoscopy: A
randomized controlled trial and meta-analysis of published studies. BMC Gastroen‐
terol 2011;11:100.
[22] Ikematsu H, Saito Y, Tanaka S, Uraoka T, Sano Y, Horimatsu T, et al. The impact of
narrow band imaging for colon polyp detection: A multicenter randomized control‐
led trial by tandem colonoscopy. J Gastroenterol 2012, Mar 3.
[23] Nagorni A, Bjelakovic G, Petrovic B. Narrow band imaging versus conventional
white light colonoscopy for the detection of colorectal polyps. Cochrane Database
Syst Rev 2012;1:CD008361.
[24] Pasha SF, Leighton JA, Das A, Harrison ME, Gurudu SR, Ramirez FC, et al. Compari‐
son of the yield and miss rate of narrow band imaging and white light endoscopy in
patients undergoing screening or surveillance colonoscopy: A meta-analysis. Am J
Gastroenterol 2012, Mar;107(3):363-70; quiz 371.
[25] Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, et al. Preva‐
lence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and
symptomatic adults. JAMA 2008, Mar 3;299(9):1027-35.
[26] Hsu W-H, Sun M-S, Lo H-W, Tsai C-Y, Tsai Y-J. Carbon dioxide insufflation during
withdrawal of the colonoscope improved postprocedure discomfort: A prospective,
randomized, controlled trial. Kaohsiung J Med Sci 2012, May;28(5):265-9.
[27] Geyer M, Guller U, Beglinger C. Carbon dioxide insufflation in routine colonoscopy
is safe and more comfortable: Results of a randomized controlled double-blinded tri‐
al. DiagnTherEndosc 2011;2011:378906.
[28] Wang WL, Wu ZH, Sun Q, Wei JF, Chen XF, Zhou DK, et al. Meta-analysis: The use
of carbon dioxide insufflation vs. Room air insufflation for gastrointestinal endos‐
copy. Aliment PharmacolTher 2012, May;35(10):1145-54.
[29] McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal can‐
cer screening 3 yr after release of national recommendations for screening. Am J Gas‐
troenterol 2007, Aug;102(8):1727-35.
[30] Hoffman-Goetz L, Thomson MD, Donelle L. Reasons for declining colorectal cancer
screening by older canadians: A pilot study. J Cancer Educ 2008;23(1):32-6.
[31] Gupta S, Saunders BP, Fraser C, Kennedy RH, Ignjatovic A, Sala S, et al. The first 3
years of national bowel cancer screening at a single UK tertiary centre. Colorectal Dis
2012, Feb;14(2):166-73.
[32] Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JME, Marshall JK, et al. How
do physician assessments of patient preferences for colorectal cancer screening tests
differ from actual preferences? A comparison in canada and the united states using a
stated-choice survey. Health Econ 2009, Dec;18(12):1420-39.
Endoscopy280
[33] Hock D, Ouhadi R, Materne R, Mancini I, Nchimi A. Screening for colorectal cancer
in asymptomatic average risk patients: Role of imaging. ActaGastroenterolBelg 2011,
Mar;74(1):70-6.
[34] Sieg A. Colon capsule endoscopy compared with conventional colonoscopy for the
detection of colorectal neoplasms. Expert Rev Med Devices 2011, Mar;8(2):257-61.
[35] Eliakim R, Yassin K, Niv Y, Metzger Y, Lachter J, Gal E, et al. Prospective multicenter
performance evaluation of the second-generation colon capsule compared with colo‐
noscopy. Endoscopy 2009, Dec;41(12):1026-31.
[36] Spada C, Hassan C, Ingrosso M, Repici A, Riccioni ME, Pennazio M, et al. A new reg‐
imen of bowel preparation for pillcam colon capsule endoscopy: A pilot study. Dig
Liver Dis 2011, Apr;43(4):300-4.
[37] Spada C, Hassan C, Galmiche JP, Neuhaus H, Dumonceau JM, Adler S, et al. Colon
capsule endoscopy: European society of gastrointestinal endoscopy (ESGE) guide‐
line. Endoscopy 2012, May;44(5):527-36.
[38] Smith EA, Dillman JR, Adler J, Dematos-Maillard VL, Strouse PJ. MR enterography
of extraluminal manifestations of inflammatory bowel disease in children and ado‐
lescents: Moving beyond the bowel wall. AJR Am J Roentgenol 2012, Jan;
198(1):W38-45.
[39] Herraiz Hidalgo L, Alvarez Moreno E, CarrascosoArranz J, Cano Alonso R, Martínez
de Vega Fernández V. [Magnetic resonance enterography: Review of the technique
for the study of crohn's disease]. Radiologia 2011;53(5):421-33.
[40] Tennyson CA, Semrad CE. Advances in small bowel imaging. CurrGastroenterol Rep
2011, Oct;13(5):408-17.
[41] Yamamoto H, Sekine Y, Sato Y, Higashizawa T, Miyata T, Iino S, et al. Total entero‐
scopy with a nonsurgical steerable double-balloon method. GastrointestEndosc 2001,
Feb;53(2):216-20.
[42] Kawamura T, Yasuda K, Tanaka K, Uno K, Ueda M, Sanada K, Nakajima M. Clinical
evaluation of a newly developed single-balloon enteroscope. GastrointestEndosc
2008, Dec;68(6):1112-6.
[43] Tsujikawa T, Saitoh Y, Andoh A, Imaeda H, Hata K, Minematsu H, et al. Novel sin‐
gle-balloon enteroscopy for diagnosis and treatment of the small intestine: Prelimina‐
ry experiences. Endoscopy 2008, Jan;40(1):11-5.
[44] Akerman PA, Cantero D. Spiral enteroscopy and push enteroscopy. GastrointestEn‐
doscClin N Am 2009, Jul;19(3):357-69.
[45] Frieling T, Heise J, Sassenrath W, Hülsdonk A, Kreysel C. Prospective comparison
between double-balloon enteroscopy and spiral enteroscopy. Endoscopy 2010, Nov;
42(11):885-8.
Innovative Uses and Emerging Technologies in Endoscopy
http://dx.doi.org/10.5772/52552
281
[46] Lennon AM, Chandrasekhara V, Shin EJ, Okolo PI. Spiral-enteroscopy-assisted enter‐
al stent placement for palliation of malignant small-bowel obstruction (with video).
GastrointestEndosc 2010, Feb;71(2):422-5.
[47] Du Y-Q, Li Z-S, Jin Z-D. Endoscope-assisted brachytherapy for pancreatic cancer:
From tumor killing to pain relief and drainage. J IntervGastroenterol 2011;1(1):23-7.
[48] Kim TH, Kim SH, Oh HJ, Sohn YW, Lee SO. Endoscopic ultrasound-guided biliary
drainage with placement of a fully covered metal stent for malignant biliary obstruc‐
tion. World J Gastroenterol 2012, May 5;18(20):2526-32.
[49] Park DH, Koo JE, Oh J, Lee YH, Moon S-H, Lee SS, et al. EUS-guided biliary drainage
with one-step placement of a fully covered metal stent for malignant biliary obstruc‐
tion: A prospective feasibility study. Am J Gastroenterol 2009, Sep;104(9):2168-74.
[50] Will U, Meyer F. [Endoscopic ultrasonography (EUS)-guided transluminalcholangio‐
drainage (EUCD) - a novel option of interventional endoscopy in the interdiciplinary
management of obstructive jaundice]. ZentralblChir 2012, Feb;137(1):20-31.
[51] Cho CM, Dewitt J, Al-Haddad M. Echo-endoscopy: New therapeutic frontiers. Min‐
erva GastroenterolDietol 2011, Jun;57(2):139-58.
[52] Ponnudurai R, Sachithanandan S, George A. Endoscopic ultrasound-guided injection
therapy for hepatobiliary disease. J HepatobiliaryPancreatSci 2011, May;18(3):311-8.
[53] Trevino JM, Varadarajulu S. Endoscopic ultrasonography-guided ablation therapy. J
HepatobiliaryPancreatSci 2011, May;18(3):304-10.
[54] Kiesslich R, Goetz M, Neurath MF. Confocal laser endomicroscopy for gastrointesti‐
nal diseases. GastrointestEndoscClin N Am 2008, Jul;18(3):451-66, viii.
[55] Matloff JL, Abidi W, Richards-Kortum R, Sauk J, Anandasabapathy S. High-resolu‐
tion and optical molecular imaging for the early detection of colonic neoplasia. Gas‐
trointestEndosc 2011, Jun;73(6):1263-73.
[56] Wallace MB, Fockens P. Probe-based confocal laser endomicroscopy. Gastroenterolo‐
gy 2009, May;136(5):1509-13.
[57] Canto MI. Endomicroscopy of barrett's esophagus. GastroenterolClin North Am
2010, Dec;39(4):759-69.
[58] Wallace MB, Sharma P, Lightdale C, Wolfsen H, Coron E, Buchner A, et al. Prelimi‐
nary accuracy and interobserver agreement for the detection of intraepithelial neo‐
plasia in barrett's esophagus with probe-based confocal laser endomicroscopy.
GastrointestEndosc 2010, Jul;72(1):19-24.
[59] Dunbar KB, Okolo P, Montgomery E, Canto MI. Confocal laser endomicroscopy in
barrett's esophagus and endoscopicallyinapparentbarrett'sneoplasia: A prospective,
randomized, double-blind, controlled, crossover trial. GastrointestEndosc 2009, Oct;
70(4):645-54.
Endoscopy282
[60] Guo Y-T, Li Y-Q, Yu T, Zhang T-G, Zhang J-N, Liu H, et al. Diagnosis of gastric intes‐
tinal metaplasia with confocal laser endomicroscopy in vivo: A prospective study.
Endoscopy 2008, Jul;40(7):547-53.
[61] Li C-Q, Li Y-Q. Endomicroscopy of intestinal metaplasia and gastric cancer. Gastro‐
enterolClin North Am 2010, Dec;39(4):785-96.
[62] Lim LG, Yeoh KG, Salto-Tellez M, Khor CJL, Teh M, Chan YH, et al. Experienced
versus inexperienced confocal endoscopists in the diagnosis of gastric adenocarcino‐
ma and intestinal metaplasia on confocal images. GastrointestEndosc 2011, Jun;73(6):
1141-7.
[63] Sanduleanu S, Driessen A, Gomez-Garcia E, Hameeteman W, de Bruïne A, Masclee
A. In vivo diagnosis and classification of colorectal neoplasia by chromoendoscopy-
guided confocal laser endomicroscopy. ClinGastroenterolHepatol 2010, Apr;8(4):
371-8.
[64] Kiesslich R, Goetz M, Lammersdorf K, Schneider C, Burg J, Stolte M, et al. Chromo‐
scopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neo‐
plasia in ulcerative colitis. Gastroenterology 2007, Mar;132(3):874-82.
[65] Goetz M, Ziebart A, Foersch S, Vieth M, Waldner MJ, Delaney P, et al. In vivo molec‐
ular imaging of colorectal cancer with confocal endomicroscopy by targeting epider‐
mal growth factor receptor. Gastroenterology 2010, Feb;138(2):435-46.
[66] Hsiung P-L, Hsiung P-L, Hardy J, Friedland S, Soetikno R, Du CB, et al. Detection of
colonic dysplasia in vivo using a targeted heptapeptide and confocal microendosco‐
py. Nat Med 2008, Apr;14(4):454-8.
[67] Hurlstone DP, Sanders DS. Recent advances in chromoscopic colonoscopy and endo‐
microscopy. CurrGastroenterol Rep 2006, Oct;8(5):409-15.
[68] Minami H, Inoue H, Yokoyama A, Ikeda H, Satodate H, Hamatani S, et al. Recent ad‐
vancement of observing living cells in the esophagus using CM double staining: En‐
docytoscopicatypia classification. Dis Esophagus 2011, Sep 9.
[69] Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, et al.
Management of antithrombotic agents for endoscopic procedures. GastrointestEn‐
dosc 2009, Dec;70(6):1060-70.
[70] Hagel A, Boxberger F, Dauth W, Kessler H, Neurath M, Raithel M. Colonoscopy-as‐
sociated perforation: A 7-year survey of in-hospital frequency, treatment and out‐
come in a german university hospital. Colorectal Dis 2011, Nov 11.
[71] Moss A, Bourke MJ, Williams SJ, Hourigan LF, Brown G, Tam W, et al. Endoscopic
mucosal resection outcomes and prediction of submucosal cancer from advanced co‐
lonic mucosal neoplasia. Gastroenterology 2011, Jun;140(7):1909-18.
Innovative Uses and Emerging Technologies in Endoscopy
http://dx.doi.org/10.5772/52552
283
[72] Schurr MO, Hartmann C, Ho C-N, Fleisch C, Kirschniak A. An over-the-scope clip
(OTSC) system for closure of iatrogenic colon perforations: Results of an experimen‐
tal survival study in pigs. Endoscopy 2008, Jul;40(7):584-8.
[73] Voermans RP, Vergouwe F, Breedveld P, Fockens P, van Berge Henegouwen MI.
Comparison of endoscopic closure modalities for standardized colonic perforations
in a porcine colon model. Endoscopy 2011, Mar;43(3):217-22.
[74] Seebach L, Bauerfeind P, Gubler C. "Sparing the surgeon": Clinical experience with
over-the-scope clips for gastrointestinal perforation. Endoscopy 2010, Dec;42(12):
1108-11.
[75] Parodi A, Repici A, Pedroni A, Blanchi S, Conio M. Endoscopic management of GI
perforations with a new over-the-scope clip device (with videos). GastrointestEndosc
2010, Oct;72(4):881-6.
[76] Grossmann J, Diening C, Althoff C. [Endoscopic closure of a chronic colonic fistula
using the over-the-scope clip (OTSC)]. Dtsch Med Wochenschr 2011, Nov;136(44):
2245-8.
[77] Manta R, Manno M, Bertani H, Barbera C, Pigò F, Mirante V, et al. Endoscopic treat‐
ment of gastrointestinal fistulas using an over-the-scope clip (OTSC) device: Case
series from a tertiary referral center. Endoscopy 2011, Jun;43(6):545-8.
[78] von Renteln D, Denzer UW, Schachschal G, Anders M, Groth S, Rösch T. Endoscopic
closure of GI fistulae by using an over-the-scope clip (with videos). GastrointestEn‐
dosc 2010, Dec;72(6):1289-96.
[79] Bini R, Coppola F, Recchia S, Fusca M, Gaia S, Leli R. Endoscopic treatment of post‐
gastrectomy duodenal fistula with an over-the-scope clip. SurgInnov 2011, Mar;18(1):
102-4.
[80] Naegel A, Bolz J, Zopf Y, Matthes K, Mueller B, Kraus F, et al. Hemodynamic efficacy
of the over-the-scope clip in an established porcine cadaveric model for spurting
bleeding. GastrointestEndosc 2012, Jan;75(1):152-9.
[81] Hearnshaw SA, Logan RFA, Lowe D, Travis SPL, Murphy MF, Palmer KR. Acute up‐
per gastrointestinal bleeding in the UK: Patient characteristics, diagnoses and out‐
comes in the 2007 UK audit. Gut 2011, Oct;60(10):1327-35.
[82] Akasaka T, Nishida T, Tsutsui S, Michida T, Yamada T, Ogiyama H, et al. Short-term
outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm:
Multicenter survey by osaka university ESD study group. Dig Endosc 2011, Jan;23(1):
73-7.
[83] Kim ES, Cho KB, Park KS, Lee KI, Jang BK, Chung WJ, Hwang JS. Factors predictive
of perforation during endoscopic submucosal dissection for the treatment of colorec‐
tal tumors. Endoscopy 2011, Jul;43(7):573-8.
Endoscopy284
[84] Schurr MO, Baur F, Ho C-N, Anhoeck G, Kratt T, Gottwald T. Endoluminal full-
thickness resection of GI lesions: A new device and technique. Minim Invasive Ther
Allied Technol 2011, May;20(3):189-92.
[85] Voermans RP, van Berge Henegouwen MI, Bemelman WA, Fockens P. Novel over-
the-scope-clip system for gastrotomy closure in natural orifice transluminal endo‐
scopic surgery (NOTES): An ex vivo comparison study. Endoscopy 2009, Dec;41(12):
1052-5.
[86] Giday SA, Kim Y, Krishnamurty DM, Ducharme R, Liang DB, Shin EJ, et al. Long-
term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325)
for control of severe arterial upper gastrointestinal bleeding in a porcine model. En‐
doscopy 2011, Apr;43(4):296-9.
[87] Sung JJY, Luo D, Wu JCY, Ching JYL, Chan FKL, Lau JYW, et al. Early clinical experi‐
ence of the safety and effectiveness of hemospray in achieving hemostasis in patients
with acute peptic ulcer bleeding. Endoscopy 2011, Apr;43(4):291-5.
Innovative Uses and Emerging Technologies in Endoscopy
http://dx.doi.org/10.5772/52552
285

